China is already gene-editing a lot of humans
A new report says at least 86 people have had their genes edited in China to help cure disease.
Backstory: We already knew that China had experimented with CRISPR gene editing in humans since 2016, becoming the first nation in the world to do so. But no human CRISPR trials have so far taken place in America.
What’s new: An investigation by the Wall Street Journal says that CRISPR gene editing has actually been used in Chinese hospitals to treat human diseases like cancer since 2015. The new report shows the extent of the trend.
How it’s possible: Unlike the US, China allows a hospital’s ethics committee to approve research on humans. CRISPR trials can be approved within an afternoon.
But: The push to use the technique isn’t necessarily a good idea. There are still safety concerns about such treatments, from immune reactions to unintended edits.
Deep Dive
Biotechnology and health
How scientists traced a mysterious covid case back to six toilets
When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.
An AI-driven “factory of drugs” claims to have hit a big milestone
Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology
The quest to legitimize longevity medicine
Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.
There is a new most expensive drug in the world. Price tag: $4.25 million
But will the latest gene therapy suffer the curse of the costliest drug?
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.